Mucosal-associated invariant T cells and disease A Toubal, I Nel, S Lotersztajn, A Lehuen Nature Reviews Immunology 19 (10), 643-657, 2019 | 266 | 2019 |
Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver P Hegde, E Weiss, V Paradis, J Wan, M Mabire, S Sukriti, PE Rautou, ... Nature communications 9 (1), 2146, 2018 | 197 | 2018 |
Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity E Dalmas, A Toubal, F Alzaid, K Blazek, HL Eames, K Lebozec, M Pini, ... Nature medicine 21 (6), 610-618, 2015 | 186 | 2015 |
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity H Flament, M Rouland, L Beaudoin, A Toubal, L Bertrand, S Lebourgeois, ... Nature Immunology 22 (3), 322-335, 2021 | 172 | 2021 |
Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity A Toubal, B Kiaf, L Beaudoin, L Cagninacci, M Rhimi, B Fruchet, ... Nature communications 11 (1), 3755, 2020 | 124 | 2020 |
MAIT cells, guardians of skin and mucosa? I Nel, L Bertrand, A Toubal, A Lehuen Mucosal immunology 14 (4), 803-814, 2021 | 95 | 2021 |
SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation A Toubal, K Clement, R Fan, P Ancel, V Pelloux, C Rouault, N Veyrie, ... The Journal of clinical investigation 123 (1), 2012 | 91 | 2012 |
Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes R Fan, A Toubal, S Goni, K Drareni, Z Huang, F Alzaid, R Ballaire, P Ancel, ... Nature medicine 22 (7), 780-791, 2016 | 88 | 2016 |
Genomic and epigenomic regulation of adipose tissue inflammation in obesity A Toubal, E Treuter, K Clement, N Venteclef Trends in Endocrinology & Metabolism 24 (12), 625-634, 2013 | 59 | 2013 |
GPS2 deficiency triggers maladaptive white adipose tissue expansion in obesity via HIF1A activation K Drareni, R Ballaire, S Barilla, MJ Mathew, A Toubal, R Fan, N Liang, ... Cell reports 24 (11), 2957-2971. e6, 2018 | 49 | 2018 |
Lights on MAIT cells, a new immune player in liver diseases A Toubal, A Lehuen Journal of Hepatology 64 (5), 1008-1010, 2016 | 23 | 2016 |
Outcome of SARS-CoV-2 infection linked to MAIT cell activation and cytotoxicity: evidence for an IL-18 dependent mechanism H Flament, M Rouland, L Beaudoin, A Toubal, L Bertrand, S Lebourgeois, ... Medrxiv, 2020.08. 31.20185082, 2020 | 12 | 2020 |
Genetic control of differential acetylation in diabetic rats PJ Kaisaki, GW Otto, JF McGouran, A Toubal, K Argoud, H Waller-Evans, ... PLoS One 9 (4), e94555, 2014 | 6 | 2014 |
Role of MAIT cells in metabolic diseases A Toubal, A Lehuen Molecular Immunology 130, 142-147, 2021 | 5 | 2021 |
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes L Castera, P Garteiser, C Laouenan, T Vidal-Trécan, A Vallet-Pichard, ... Journal of Hepatology, 2024 | 3 | 2024 |
The BMAL2 circadian clock gene controls inflammation and metabolic adaptation in adipose tissue during diet-induced obesity MA Philippe, B Fruchet, E Challet, A Lehuen, A Toubal, UC Rogner The EASD Annual Meeting 2023, 2023 | | 2023 |
Migration des cellules MAIT dans les tissus métaboliques chez le patient obèse B Fruchet, M Philippe, V Amélie, A Bado, M Le Gall, L Ribeiro-Parenti, ... Congrès annuel de la société francophone du diabète, 2023 | | 2023 |
Non Classical MHC presentation to Non-classical lymphocytesMR1-restricted T cell activation in physiopathology A Toubal, L Beaudoin, J Da Silva, A Lehuen Molecular Immunology 150, 14, 2022 | | 2022 |
Use of an agent capable of inhibiting the activation of mait cells for the treatment of obesity and obesity-related disorders A Lehuen-monteiro, A Toubal US Patent App. 17/440,351, 2022 | | 2022 |
Le rôle des cellules MAIT dans les tissus métaboliques durant l'obésité B Fruchet, M Philippe, UC Rogner, A Lehuen, A Toubal Congrès SFD 2022-Société Francophone du Diabète, 2022 | | 2022 |